At the time of writing, Willis Towers Watson Public Limited Co [WTW] stock is trading at $339.65, up 1.30%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The WTW shares have gain 4.20% over the last week, with a monthly amount glided 4.66%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Willis Towers Watson Public Limited Co [NASDAQ: WTW] stock has seen the most recent analyst activity on January 08, 2025, when Evercore ISI upgraded its rating to a Outperform and also boosted its price target to $373 from $357. Previously, Jefferies upgraded its rating to Buy on December 20, 2024, and elevated its price target to $382. On December 05, 2024, upgrade upgraded it’s rating to Strong Buy and revised its price target to $400 on the stock. Barclays started tracking the stock assigning a Underweight rating and suggested a price target of $278 on September 05, 2024. BofA Securities upgraded its rating to a Neutral and raised its price target to $304 on May 22, 2024. Citigroup upgraded its rating to Buy for this stock on February 12, 2024, and upped its price target to $315. In a note dated February 12, 2024, BMO Capital Markets upgraded an Market Perform rating on this stock and boosted its target price from $236 to $298.
For the past year, the stock price of Willis Towers Watson Public Limited Co fluctuated between $245.04 and $339.12. Currently, Wall Street analysts expect the stock to reach $353.33 within the next 12 months. Willis Towers Watson Public Limited Co [NASDAQ: WTW] shares were valued at $339.65 at the most recent close of the market. An investor can expect a potential return of 4.03% based on the average WTW price forecast.
Analyzing the WTW fundamentals
According to Willis Towers Watson Public Limited Co [NASDAQ:WTW], the company’s sales were 9.93B for trailing twelve months, which represents an 4.15% jump. Gross Profit Margin for this corporation currently stands at 0.61% with Operating Profit Margin at 0.09%, Pretax Profit Margin comes in at 0.01%, and Net Profit Margin reading is -0.01%. To continue investigating profitability, this company’s Return on Assets is posted at -0.0, Equity is -0.01 and Total Capital is 0.06. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.73.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 336.29 points at the first support level, and at 332.93 for the second support level. However, for the 1st resistance point, the stock is sitting at 341.45, and for the 2nd resistance point, it is at 343.25.
Ratios To Look Out For
Considering the valuation of this stock, the price to sales ratio is 3.41, the price to book ratio is 4.27.
Transactions by insiders
Recent insider trading involved Gebauer Julie Jarecke, Pres.-Health, Wealth & Career, that happened on Feb 28 ’25 when 3384.0 shares were sold. Officer, Gebauer Julie Jarecke completed a deal on Feb 28 ’25 to buy 3384.0 shares.
